nilvadipine has been researched along with Hepatitis in 1 studies
Hepatitis: INFLAMMATION of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fourteen normotensive patients with liver disease (6 with cirrhosis and 8 with chronic hepatitis) and 7 healthy volunteers were given a single oral dose of nilvadipine 2 mg." | 3.68 | Elevated plasma nilvadipine concentration after single and chronic oral administration to patients with chronic liver disease. ( Fujishima, M; Ito, Y; Kikuchi, M; Kobayashi, K; Takata, Y; Tsukashima, A; Ueno, M; Yoshizumi, T, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takata, Y | 1 |
| Yoshizumi, T | 1 |
| Ito, Y | 1 |
| Kikuchi, M | 1 |
| Ueno, M | 1 |
| Tsukashima, A | 1 |
| Kobayashi, K | 1 |
| Fujishima, M | 1 |
1 other study available for nilvadipine and Hepatitis
| Article | Year |
|---|---|
Elevated plasma nilvadipine concentration after single and chronic oral administration to patients with chronic liver disease.
Topics: Administration, Oral; Calcium Channel Blockers; Chronic Disease; Hemodynamics; Hepatitis; Humans; Li | 1992 |